What is the real-world eligibility rate for bladder preservation treatment in patients with muscle-invasive bladder cancer?

被引：0
|
作者：
Abu Ghanem, Y. [1 ]
Omar, K. [2 ]
Kam, J. [1 ]
Mensah, E. [1 ]
Mohamed, G. [1 ]
Nair, R. [1 ]
Thurairaja, R. [1 ]
Khan, S. [1 ]
机构：
[1] Guys & St Thomas NHS Fdn Trust, Dept Urol, London, England
[2] Kings Coll Hosp NHS Fdn Trust, Dept Urol, London, England
来源：
EUROPEAN UROLOGY | 2024年 / 85卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
P206
引用
收藏
页码：S286 / S286
页数：1
相关论文
共 50 条
  • [1] Bladder preservation in muscle-invasive bladder cancer
    Stackl, W
    Baierlein, M
    Albrecht, W
    BRITISH JOURNAL OF UROLOGY, 1998, 82 (03): : 357 - 360
  • [2] Real-world Outcomes of Bladder Carbogen and Nicotinamide (BCON) in Muscle-invasive Bladder Cancer (MIBC)
    Lodhi, T.
    Song, Y. P.
    Elumalai, T.
    Mistry, H.
    Hoskin, P.
    Choudhury, A.
    CLINICAL ONCOLOGY, 2023, 35 (02) : E240 - E241
  • [3] Defining cisplatin eligibility in patients with muscle-invasive bladder cancer
    Di Maria Jiang
    Shilpa Gupta
    Abhijat Kitchlu
    Alejandro Meraz-Munoz
    Scott A. North
    Nimira S. Alimohamed
    Normand Blais
    Srikala S. Sridhar
    Nature Reviews Urology, 2021, 18 : 104 - 114
  • [4] Defining cisplatin eligibility in patients with muscle-invasive bladder cancer
    Jiang, Di Maria
    Gupta, Shilpa
    Kitchlu, Abhijat
    Meraz-Munoz, Alejandro
    North, Scott A.
    Alimohamed, Nimira S.
    Blais, Normand
    Sridhar, Srikala S.
    NATURE REVIEWS UROLOGY, 2021, 18 (02) : 104 - 114
  • [5] Editorial comment: bladder preservation as a treatment strategy in muscle-invasive bladder cancer
    Ajib, Khaled
    Kulkarni, Girish S.
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2018, 7 : S723 - S726
  • [6] Patterns and predictors of treatment in muscle-invasive bladder cancer (MIBC): A real-world study.
    Lu, Zengqi
    Clement, Jessica M.
    Pan, Qi
    Swede, Helen
    Mehta, Rajni
    Wang, Xiaoyan
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [7] A balanced perspective on bladder preservation and systemic treatment in muscle-invasive bladder cancer
    Lin, Fu-Xiang
    Wang, Lei
    Xu, Zhan-Ping
    WORLD JOURNAL OF UROLOGY, 2024, 42 (01)
  • [8] OUTCOMES OF BLADDER PRESERVATION THERAPY ON SURVIVAL IN PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER
    Ozaydin, Sukru
    Atas, Erman
    Karadurmus, Nuri
    Emirzeoglu, Levent
    Arpaci, Fikret
    ARCHIVOS ESPANOLES DE UROLOGIA, 2020, 73 (01): : 41 - 46
  • [9] Hypofractionated chemoradiotherapy for bladder preservation in muscle-invasive bladder cancer
    Krishnan, Anuradha
    Kashid, Sheetal
    Pansande, Namrata
    Maitre, Priyamvada
    Singh, Pallavi
    Joshi, Amit
    Phuralipatram, Reena
    Prakash, Gagan
    Pal, Mahendra
    Arora, Amandeep
    Murthy, Vedang
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S2499 - S2502
  • [10] Trimodality Bladder Preservation Therapy for Muscle-Invasive Bladder Cancer
    Chen, Ronald C.
    Shipley, William U.
    Efstathiou, Jason A.
    Zietman, Anthony L.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2013, 11 (08): : 952 - 960
12345